FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)

K Number: K232967 · Decision Jun 12, 2024
Classifications
1
FEI Numbers
7
Registration Numbers
7
Same Product Code
20
Applicant Total
29
Review Days
265

Basic Information

Device Name
VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)
K Number
K232967
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.1640
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
bioMerieux, Inc.
Date Received
September 21, 2023
Decision Date
June 12, 2024
Product Code
NGZ
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NGZ Susceptibility Test Plate, Antifungal

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NGZ), ordered by most recent decision date.

View all

Other Clearances by bioMerieux, Inc.

K Number Device Name
K232963 VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)
K234000 VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL)
K222378 VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL)
K213899 VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin
K213931 VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL)
K212461 VITEK MS PRIME
K202396 VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL)
K201675 VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL)
K191766 VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL)
K190616 VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL)
Search all 29 clearances from bioMerieux, Inc. →